 | Up a level |
De Wit, S; Battegay, M; D'Arminio Monforte, A; Lundgren, J D; Oprea, C; Antinori, A; Bhagani, S; Fätkenheuer, G; Friis-Moller, N; Furrer, Hansjakob; Mussini, C (2018). European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary. HIV medicine, 19(2), pp. 77-80. Blackwell Science 10.1111/hiv.12559
Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462
The, Antiretroviral Therapy (ART) Cohort Collaboration; Sterne, JA; May, M; Sabin, C; Phillips, A; Costagniola, D; Chêne, G; Justice, AC; De Wolf, F; Hogg, R; Battegay, M; D'Arminio Monforte, A; Fätkenheuer, G; Staszewski, S; Gill, J; Egger, M (2007). Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. Journal of acquired immune deficiency syndromes JAIDS, 46(5), pp. 607-615. Philadelphia, Pa.: Lippincott Williams & Wilkins
May, MT; Sterne, JA; Costagliola, D; Sabin, CA; Phillips, AN; Justice, AC; Dabis, F; Gill, J; Lundgren, J; Hogg, RS; de Wolf, F; Fätkenheuer, G; Staszewski, S; d'Arminio Monforte, A; Egger, Matthias; The Antiretroviral Therapy (ART) Cohort Collaboration, (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet, 368(9534), pp. 451-458. London: Elsevier 10.1016/S0140-6736(06)69152-6
